Equine Healthcare Market by Product (Drugs, Vaccines, Medicated Feed Additives, Diagnostics, and Others), Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, R

Equine Healthcare Market by Product (Drugs, Vaccines, Medicated Feed Additives, Diagnostics, and Others), Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Rabies, and Others), Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies and Drug Stores), and Region 2024-2032


The global equine healthcare market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.

Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.

Equine Healthcare Market Trends:
The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global equine healthcare market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, indication, and distribution channel.

Product Insights:

Drugs
Anti-Inflammatory Drugs
Parasiticide Drugs
Others
Vaccines
Live Attenuated Vaccine
Recombinant Vaccine
Others
Medicated Feed Additives
Diagnostics
Others

The report has provided a detailed breakup and analysis of the equine healthcare market based on the product. This includes drugs (anti-inflammatory drugs, parasiticide drugs, and others), vaccines (live attenuated vaccine, recombinant vaccine, and others), medicated feed additives, diagnostics, and others. According to the report, drugs represented the largest segment.

Indication Insights:

Musculoskeletal Disorders
Parasite Control
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
Rabies
Others

A detailed breakup and analysis of the equine healthcare market based on the indication has also been provided in the report. This includes musculoskeletal disorders, parasite control, equine herpes virus, equine encephalomyelitis, equine influenza, West Nile virus, tetanus, rabies, and others. According to the report, parasite control accounted for the largest market share.

Distribution Channel Insights:

Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores

A detailed breakup and analysis of the equine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals and clinics and retail pharmacies and drug stores. According to the report, veterinary hospitals and clinics accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global equine healthcare market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global equine healthcare market?
What is the impact of each driver, restraint, and opportunity on the global equine healthcare market?
What are the key regional markets?
Which countries represent the most attractive equine healthcare market?
What is the breakup of the market based on the product?
Which is the most attractive product in the equine healthcare market?
What is the breakup of the market based on the indication?
Which is the most attractive indication in the equine healthcare market?
What is the breakup of the market based on distribution channel?
Which is the most attractive distribution channel in the equine healthcare market?
What is the competitive structure of the global equine healthcare market?
Who are the key players/companies in the global equine healthcare market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Equine Healthcare Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Drugs
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Anti-Inflammatory Drugs
6.1.2.2 Parasiticide Drugs
6.1.2.3 Others
6.1.3 Market Forecast
6.2 Vaccines
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Live Attenuated Vaccine
6.2.2.2 Recombinant Vaccine
6.2.2.3 Others
6.2.3 Market Forecast
6.3 Medicated Feed Additives
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Diagnostics
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Indication
7.1 Musculoskeletal Disorders
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Parasite Control
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Equine Herpes Virus
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Equine Encephalomyelitis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Equine Influenza
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 West Nile Virus
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Tetanus
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Rabies
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Veterinary Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies and Drug Stores
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Boehringer Ingelheim International GmbH
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 Ceva
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Dechra Pharmaceuticals PLC
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Elanco Animal Health Incorporated
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Esaote SpA
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Hallmarq Veterinary Imaging
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 IDEXX Laboratories Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Merck & Co. Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Vetoquinol S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Zoetis Inc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings